EUVIMEDEUVIMED entdecken
Crossref

Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Uğur Köktürk iD, Hamdi Püşüroğlu, Mustafa Umut Somuncu, Özgür Akgül, Begüm Uygur iD, Sinem Özyılmaz, Nilgün Işıksaçan iD, Özgür Sürgit, Aydın Yıldırım

Angiology · 2023-10 · 74 (9) · 889-896

DOI: 10.1177/00033197221149846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, online erschienen am 03.01.2023. Verfasst von Uğur Köktürk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Heart Failure. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the short and long-term prognostic value of galectin-3 in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Patients (n = 143) were admitted with STEMI and followed up for 2 years. The study population was divided into high and low galectin-3 groups based on the admission median value of serum galectin-3. Primary clinical outcomes consisted of cardiovascular (CV) mortality, non-fatal reinfarction, stroke, and target vessel revascularization (TVR). CV events were recorded in hospital and at 1 and 2 years. The primary clinical outcomes (in-hospital, 1 year and 2 year) were significantly higher in the high galectin-3 group. ( P = .008, P = .004, P = .002, respectively). High galectin-3 levels were also associated with heart failure development and re-hospitalization at both 1 year ( P = .029, P = .009, respectively) and 2 years ( P = .019, P = .036, respectively). According to Cox multivariate analysis, left ventricular ejection fraction (LVEF) was an independent predictor of 2-year cardiovascular mortality ( P = .009), whereas galectin-3 was not ( P = .291). Although high galectin-3 levels were not independent predictors of long-term CV mortality in patients with acute STEMI who underwent primary PCI, it was associated with short-term and long-term development of adverse CV events, heart failure, and re-hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionPercutaneous Coronary InterventionHeart FailureHumansPrognosisGalectin 3Stroke VolumeTreatment OutcomeVentricular Function, Left

Stichwörter der Autor:innen

ST-elevation myocardial infarctiongalectin-3primary angioplasty

Substanzen

Galectin 3

Autor:innen und Institutionen

  • Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey.
  • Department of Biochemistry, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Uğur Köktürk, Begüm Uygur, Nilgün Işıksaçan

Zitieren

APA

Köktürk, U., Püşüroğlu, H., Somuncu, M. U., Akgül, Ö., Uygur, B., Özyılmaz, S., Işıksaçan, N., Sürgit, Ö., & Yıldırım, A. (2023). Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology, 74(9), 889-896. https://doi.org/10.1177/00033197221149846

Vancouver

Köktürk U, Püşüroğlu H, Somuncu MU, Akgül Ö, Uygur B, Özyılmaz S, et al. Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2023;74(9):889-896. doi:10.1177/00033197221149846

BibTeX
@article{Kktrk2023,
  author = {Köktürk, Uğur and Püşüroğlu, Hamdi and Somuncu, Mustafa Umut and Akgül, Özgür and Uygur, Begüm and Özyılmaz, Sinem and Işıksaçan, Nilgün and Sürgit, Özgür and Yıldırım, Aydın},
  title = {Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention},
  journal = {Angiology},
  year = {2023},
  volume = {74},
  number = {9},
  pages = {889--896},
  doi = {10.1177/00033197221149846}
}
Kostenlos starten →